FDAHealthMarch 6, 2026
PAYLESS COMPOUNDERS, LLC — Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR
⚠️ Lack of Assurance of Sterility
Is this relevant to me?
- Geography
- OR
- Source agency
- FDA
- Category
- Health
- Published
- March 6, 2026
OR
What's affected?
- Product
- Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR
- Lot code
- 01-27-2026@14S
Additional details
Lot Number 01-27-2026@14S.5
What should I do?
Recommended action
Class II recall. Voluntary: Firm initiated Quantity affected: 91 vials.
Get Health recall alerts
Delivered to your inbox. Free. No account required.